Filler injections are often applied to reshape facial contours. Facial fillers are substances injected into the skin to smooth wrinkles and make them less noticeable. Facial filler injection is an outpatient procedure usually performed with numbing medication. The process is completed in a short time. How long the effect lasts depends on the type of wrinkle and filler, among other factors.
Facial fillers or soft tissue fillers are generally not used in people with suppressed immune systems or those taking blood thinning medications (anticoagulants).
Facial fillers include:
As with any procedure, there are some risks to injecting filler into the face for wrinkles. For example, allergic reaction, swelling and inflammation at the injection site or in the body, changes in skin color on dark skin, mild pain, bleeding or bruising at the injection site, infection, scarring or irregularities in the surface, lines and firmness of the skin may occur.
Today in the UK, it is considered an offense to administer botulinum toxin and cosmetic fillers to children under the age of 18, even if a person over the age of 18 has consent.
Today, in many countries, drugs, medical devices and blood components for transfusion are regulated. Organizations responsible for regulating medical devices include within the scope of medical device regulations products that the manufacturer claims are solely for aesthetic or other non-medical purposes, but which are similar to medical devices in their operation and use. In this way, dermal fillers are also subject to stricter regulations.
Government organizations seek to support the public in making safe and informed choices about non-surgical cosmetic procedures they may choose to undergo. There is serious concern about the lack of regulation in the field of non-surgical cosmetic procedures and the dangers this poses to public safety.
Restricting cosmetic procedures is seen as a two-step process:
All dermal filler products are approved by the US Food and Drug Administration (FDA) according to the standard "ISO 10993-1 Biological evaluation of medical devices - Part 1: Evaluation and testing in the risk management process", implantable products that come into contact with tissue for more than 30 days. It is evaluated in terms of biocompatibility. If the product is collagen-based, the risk of hypersensitivity reaction is also evaluated. Preclinical evaluation also includes evaluation and testing of product chemistry and materials engineering.
given to businesses by our organization Among numerous testing, measurement, analysis and evaluation studies, there are also medical analysis services of filler injections.